Clinical Trial Update: Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating gemcitabine and cisplatin with or without cetuximab in urothelial cancer (bladder cancer); results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Urothelial Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Cetuximab (cetuximab)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Bladder Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-10-27